CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling

In this study we demonstrate for the first time that therapeutic transfer of CD4+CD25+ regulatory T cells can resolve features of chronic allergen-induced inflammation and prevent development of airway remodeling.